Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fallon

Showing results (221-230 of 235) with videos related to

Pageof 24
Sort By:
Immunity|June 17, 2018
Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid CellsTimotheus Y F Halim, Batika M J Rana, Jennifer A Walker, et al.
Plos Pathogens|July 9, 2011
A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteinsAnthony Ryan, Mark Lynch, Sinead M Smith, et al.
The Journal of Investigative Dermatology|September 4, 2019
Filaggrin Expression and Processing Deficiencies Impair Corneocyte Surface Texture and Stiffness in MiceJacob P Thyssen, Ivone Jakasa, Christoph Riethmüller, et al.
Blood|July 18, 2025
The interleukin-33 receptor (ST2) is a novel therapeutic target to attenuate the progression of hemophilic arthropathyHeike C Hawerkamp, Aoife Yeow, Ciara Byrne, et al.
Mucosal Immunology|May 28, 2020
Group-2 innate lymphoid cell-dependent regulation of tissue neutrophil migration by alternatively activated macrophage-secreted Ear11Veera Panova, Mayuri Gogoi, Noe Rodriguez-Rodriguez, et al.
Science Translational Medicine|February 12, 2016
Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipaseRachael Jarrett, Mariolina Salio, Antonia Lloyd-Lavery, et al.
Science Advances|April 13, 2022
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancerMohamed S Hasim, Marie Marotel, Jonathan J Hodgins, et al.
JCI Insight|September 10, 2024
Emergence of dysfunctional neutrophils with a defect in arginase-1 release in severe COVID-19Amrita Dwivedi, Aisling Ui Mhaonaigh, Makala Carroll, et al.
Science Translational Medicine|September 4, 2015
Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammationShaun Spence, Michelle K Greene, François Fay, et al.
Frontiers in Immunology|April 17, 2023
Characterisation of the pro-inflammatory cytokine signature in severe COVID-19Heike C Hawerkamp, Adam H Dyer, Neha D Patil, et al.
Pageof 24

Showing results (221-230 of 235) with videos related to

Sort By:
Pageof 24
Immunity|June 17, 2018
Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid CellsTimotheus Y F Halim, Batika M J Rana, Jennifer A Walker, et al.
Plos Pathogens|July 9, 2011
A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteinsAnthony Ryan, Mark Lynch, Sinead M Smith, et al.
The Journal of Investigative Dermatology|September 4, 2019
Filaggrin Expression and Processing Deficiencies Impair Corneocyte Surface Texture and Stiffness in MiceJacob P Thyssen, Ivone Jakasa, Christoph Riethmüller, et al.
Blood|July 18, 2025
The interleukin-33 receptor (ST2) is a novel therapeutic target to attenuate the progression of hemophilic arthropathyHeike C Hawerkamp, Aoife Yeow, Ciara Byrne, et al.
Mucosal Immunology|May 28, 2020
Group-2 innate lymphoid cell-dependent regulation of tissue neutrophil migration by alternatively activated macrophage-secreted Ear11Veera Panova, Mayuri Gogoi, Noe Rodriguez-Rodriguez, et al.
Science Translational Medicine|February 12, 2016
Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipaseRachael Jarrett, Mariolina Salio, Antonia Lloyd-Lavery, et al.
Science Advances|April 13, 2022
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancerMohamed S Hasim, Marie Marotel, Jonathan J Hodgins, et al.
JCI Insight|September 10, 2024
Emergence of dysfunctional neutrophils with a defect in arginase-1 release in severe COVID-19Amrita Dwivedi, Aisling Ui Mhaonaigh, Makala Carroll, et al.
Science Translational Medicine|September 4, 2015
Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammationShaun Spence, Michelle K Greene, François Fay, et al.
Frontiers in Immunology|April 17, 2023
Characterisation of the pro-inflammatory cytokine signature in severe COVID-19Heike C Hawerkamp, Adam H Dyer, Neha D Patil, et al.
Pageof 24